MiNK Therapeutics (INKT) Institutional Ownership $0.52 +0.02 (+4.76%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for MiNK Therapeutics (NASDAQ:INKT)CurrentInstitutional OwnershipPercentage2.87%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$21.46KNumber ofInstitutional Sellers(last 12 months)0 Get INKT Insider Trade Alerts Want to know when executives and insiders are buying or selling MiNK Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data INKT Institutional Buying and Selling by Quarter Ad WealthPress70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << MiNK Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/9/2024 Renaissance Technologies LLC127,841$121K0.0%+21.5%0.368% 11/14/2023 Oracle Investment Management Inc.36,898$41K0.0%-26.9%0.107% 8/14/2023 Oracle Investment Management Inc.50,461$106K0.1%N/A0.146% 8/14/2023 Deep Track Capital LP324,867$682K0.0%N/A0.941% 8/11/2023 Artal Group S.A.228,216$479K0.0%-21.2%0.663% 7/27/2023 Virtu Financial LLC14,232$30K0.0%N/A0.041% 2/10/2023 StoneX Group Inc.17,821$47K0.0%N/A0.053% 11/4/2022First Republic Investment Management Inc.81,500$172K0.0%N/A0.243% 2/15/2022 Sofinnova Investments Inc.345,499$1.54M0.1%N/A1.031% (Data available from 1/1/2016 forward) INKT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of INKT shares? During the previous two years, the following institutional investors and hedge funds held shares of MiNK Therapeutics shares: Deep Track Capital LP ($682K), Artal Group S.A. ($479K), Renaissance Technologies LLC ($121K), StoneX Group Inc. ($47K), and Oracle Investment Management Inc. ($41K), Virtu Financial LLC ($30K).Learn more on INKT's institutional investors. What percentage of MiNK Therapeutics stock is owned by institutional investors? 2.87% of MiNK Therapeutics stock is owned by institutional investors. Learn more on INKT's institutional investor holdings. Which institutional investors have been buying MiNK Therapeutics stock? The following institutional investors have purchased MiNK Therapeutics stock in the last 24 months: Deep Track Capital LP ($324.87K), Oracle Investment Management Inc. ($50.46K), Renaissance Technologies LLC ($22.61K), StoneX Group Inc. ($17.82K), and Virtu Financial LLC ($14.23K). How much institutional buying is happening at MiNK Therapeutics? Institutional investors have bought a total of 429,994 shares in the last 24 months. This purchase volume represents approximately $886.05K in transactions. Which MiNK Therapeutics major shareholders have been selling company stock? The following institutional investors have sold MiNK Therapeutics stock in the last 24 months: Artal Group S.A. ($61.37K), and Oracle Investment Management Inc. ($13.56K). How much institutional selling is happening at MiNK Therapeutics? Institutional investors have sold a total of 74,935 shares in the last 24 months. This volume of shares sold represents approximately $143.80K in transactions. Related Companies Rani Therapeutics Institutional Ownership Assertio Institutional Ownership Anixa Biosciences Institutional Ownership Adagene Institutional Ownership PowerUp Acquisition Institutional Ownership CytomX Therapeutics Institutional Ownership 23andMe Institutional Ownership Adlai Nortye Institutional Ownership Karyopharm Therapeutics Institutional Ownership Reviva Pharmaceuticals Institutional Ownership This page (NASDAQ:INKT) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiNK Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MiNK Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INKT Stock Alerts